Clinical Practice
Bysanti (Milsaperidone) FDA Approval: What PMHNPs Need to Know
The FDA just approved Bysanti (milsaperidone) for bipolar I and schizophrenia. Here's what PMHNPs need to know about dosing, monitoring, and where it fits in your prescribing toolkit.